Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1a,Condition 1b 141,"Lan H, et al., Genetics 2001 Jan;157(1):331-9",mammary gland integrity trait,,RS:0000984,WF/NHsd,female,174 days to 169 days,21,,CMO:0000343,mammary tumor number,,3X3 mm diameter or larger,,7.3,,0.982,4.5,MMO:0000344,necropsy,,,,,,,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) ",11742,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) ", 142,"Samuelson DJ, et al., Carcinogenesis 2003 Sep;24(9):1455-60",mammary gland integrity trait,,RS:0000984,WF/NHsd,female,160 days to 155 days,50,,CMO:0000343,mammary tumor number,,3X3 mm diameter or larger,,6.9,,0.4,2.8284,MMO:0000160,unspecified method,,,,,,,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) ",11743,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) ", 143,"Haag JD, et al., Cancer Res 2003 Sep 15;63(18):5808-12",mammary gland integrity trait,,RS:0000984,WF/NHsd,female,160 days to 155 days,30,,CMO:0000343,mammary tumor number,,3X3 mm diameter or larger,,8.1,,0.7,3.8341,MMO:0000344,necropsy,,,,,,,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) ",11746,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) ", 653,"Veillet AL, et al., Cancer Prev Res (Phila). 2011 Jan;4(1):97-106.",mammary gland integrity trait,,RS:0000984,WF/NHsd,female,160 days to 155 days,46,,CMO:0000343,mammary tumor number,,,,7.9,,0.5,3.3912,MMO:0000163,in vivo visual assessment,,0.0,,,,,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)",70314,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 105 days)", 143,"Haag JD, et al., Cancer Res 2003 Sep 15;63(18):5808-12",mammary gland integrity trait,,RS:0000984,WF/NHsd,female,160 days to 155 days,29,,CMO:0000343,mammary tumor number,,3X3 mm diameter or larger,,6.3,,0.5,2.6926,MMO:0000344,necropsy,,0.0,,,,,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) ",70167,"7,12-dimethyltetraphene (DMBA) (65 mg/kg) ", 1178,"de Graaf KL, et al., J Neuroimmunol. 2004 Oct;155(1-2):73-84.",peripheral nervous system integrity trait,peripheral nervous system integrity trait,RS:0000984,WF/NHsd,male,200 days to 98 days,5,,CMO:0001522,percentage of study population developing experimental autoimmune neuritis during a period of time,,,,0,%,,,MMO:0000162,ex vivo visual assessment,,0.0,,,,,peripheral myelin protein 2 peptide 58-81 (100 ug) and Freund's complete adjuvant (100 ul) ,84525,peripheral myelin protein 2 peptide 58-81 (100 ug) ,Freund's complete adjuvant (100 ul) 1178,"de Graaf KL, et al., J Neuroimmunol. 2004 Oct;155(1-2):73-84.",peripheral nervous system integrity trait,peripheral nervous system integrity trait,RS:0000984,WF/NHsd,male,200 days to 98 days,5,,CMO:0001522,percentage of study population developing experimental autoimmune neuritis during a period of time,,,,0,%,,,MMO:0000162,ex vivo visual assessment,,0.0,,,,,peripheral nerve myelin (2 mg) and Freund's complete adjuvant (100 ul) ,84475,peripheral nerve myelin (2 mg) ,Freund's complete adjuvant (100 ul)